Cargando…
Vaccinations against human papillomavirus missed because of COVID-19 may lead to a rise in preventable cervical cancer
Autores principales: | Diamond, Laura M., Clarfield, Lauren E., Forte, Milena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476220/ https://www.ncbi.nlm.nih.gov/pubmed/34544788 http://dx.doi.org/10.1503/cmaj.80082 |
Ejemplares similares
-
Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers
por: Nayereh, Khadem Ghaebi, et al.
Publicado: (2012) -
Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009) -
Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2
por: Clarfield, Lauren, et al.
Publicado: (2022) -
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
por: Liu, Pang-Hsiang, et al.
Publicado: (2010) -
Hypomagnesemia because of nedaplatin for cervical cancer: A case report
por: Komoda, Jun, et al.
Publicado: (2023)